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Abstract  24 
 25 
Candidate vaccine viruses (CVVs) for seasonal influenza A virus are made by 26 
reassortment of the antigenic virus with an egg-adapted strain, typically A/Puerto Rico/8/34 27 
(PR8). Many 2009 A(H1N1) pandemic (pdm09) high-growth reassortants (HGRs) selected 28 
this way contain pdm09 segment 2 in addition to the antigenic genes. To investigate this, 29 
we made CVV mimics by reverse genetics (RG) that were either 6:2 or 5:3 reassortants 30 
between PR8 and two pdm09 strains, A/California/7/2009 (Cal7) and A/England/195/2009, 31 
differing in the source of segment 2. The 5:3 viruses replicated better in MDCK-SIAT1 32 
cells than the 6:2 viruses, but the 6:2 CVVs gave higher HA antigen yields from eggs. This 33 
unexpected phenomenon reflected temperature sensitivity conferred by pdm09 segment 2, 34 
as egg HA yields of the 5:3 viruses improved substantially when viruses were grown at 35 
35°C compared with 37.5°C, whereas 6:2 virus yield did not. However, authentic 5:3 36 
pdm09 HGRs, X-179A and X-181, were not markedly temperature-sensitive despite their 37 
PB1 sequences being identical to Cal7, suggesting compensatory mutations elsewhere in 38 
the genome. Sequence comparisons of the PR8-derived backbone genes identified 39 
polymorphisms in PB2, NP, NS1, and NS2. Of these, PB2 N701D affected the temperature 40 
dependency of viral transcription and furthermore, improved and drastically reduced the 41 
temperature sensitivity of HA yield from the 5:3 CVV mimic. We conclude that HA yield 42 
of pdm09 CVVs can be affected by an epistatic interaction between PR8 PB2 and pdm09 43 
PB1 but that this can be minimised by ensuring that backbones used for vaccine 44 
manufacture in eggs contain PB2 701D. 45 
 46 
Keywords: influenza, vaccine, PB1, PB2, temperature sensitive47 
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Introduction 48 
 49 
Worldwide, annual influenza epidemics result in three to five million cases of 50 
severe illness, and 290,000 to 650,000 deaths [1]. Both influenza A viruses (IAV) and 51 
influenza B viruses cause seasonal disease but IAV poses additional risks of sporadic 52 
zoonotic infections and novel pandemic strains. IAVs are divided into subtypes by their 53 
antigenic determinants, the surface glycoproteins haemagglutinin (HA) and 54 
neuraminidase (NA). Pandemics have occurred with A(H1N1) (in 1918 and 2009), 55 
A(H2N2) (1957) and A(H3N2) (1968) subtype viruses; currently circulating epidemic 56 
viruses descended from these are from the H3N2 and 2009 A(H1N1) (pdm09) lineages.  57 
 The primary measure to control influenza is vaccination. Seasonal vaccine 58 
production techniques rely on classical reassortment to generate viruses with good 59 
growth properties in embryonated hens’ eggs, the major manufacturing substrate. This 60 
involves co-infecting eggs with the antigenic (vaccine strain) virus of choice along with 61 
a high yielding (“donor”) virus already adapted to growth in eggs. Reassortant viruses 62 
that contain the HA and NA of the vaccine viruses are selected and the highest yielding 63 
viruses, (high growth reassortants or HGRs), are designated as candidate vaccine 64 
viruses (CVVs). Generating HGRs with the desired growth properties can be difficult 65 
and sometimes requires further passaging of the initial reassortants to further adapt 66 
them to growth in eggs, which can also induce unwanted antigenic changes to the HA 67 
[2-7].  68 
An alternative, potentially quicker method to generate HGRs that, conceptually 69 
at least, reduces potential antigenic changes, involves using reverse genetics (RG) to 70 
create the desired strain [8-10]. This method involves generation of virus by 71 
transfection of cells with plasmids encoding the eight genomic segments of IAV which 72 
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transcribe both viral mRNA and negative sense viral RNA (vRNA), resulting in the de 73 
novo production of virus particles. Typically, the six viral backbone segments 74 
(segments 1 - 3, 5, 7 and 8) are derived from the egg-adapted donor strain, whereas the 75 
two segments encoding HA and NA are derived from the vaccine strain. This “6:2” 76 
reassortant can then be produced in large scale in eggs. When large amounts of vaccine 77 
need to produced quickly, RG methods may be preferred over classical reassortment. 78 
Moreover, RG is the only currently viable method to produce CVVs for highly 79 
pathogenic avian IAV strains, since it allows the deletion of polybasic sequences that 80 
are determinants for high pathogenicity from the virus HA. 81 
A limited number of donor strains for IAV vaccine manufacture exist. The strain 82 
that underpins both classical reassortment and RG approaches is the A/Puerto Rico/8/34 83 
strain (PR8). However, reassortant IAVs with PR8 backbone segments do not always 84 
grow sufficiently well to ensure efficient vaccine manufacture [67], prompting the need 85 
for better understanding of the molecular determinants of CVV fitness. Analysis of 86 
conventionally derived HGR viruses has shown that as expected, PR8-derived internal 87 
segments predominate, with 6:2 and 5:3 (PR8:WT virus) reassortants representing the 88 
most common gene constellations. Of the 5:3 HGRs, segment 2 is the most common 89 
third vaccine virus-derived segment, especially in human pdm09, but also in H3N2 and 90 
H2N2 subtypes  [11, 12]. In addition, an avian H5N2 5:3 reassortant was shown to 91 
produce higher yields than its 6:2 counterpart [13]. Since all 6 internal PR8 gene 92 
segments are presumably adapted to growth in eggs, this preference for the vaccine 93 
strain PB1 gene perhaps indicates that it confers a growth advantage in the presence of 94 
the vaccine strain HA and/or NA genes. Supporting this, many studies have used RG 95 
to confirm that introducing a vaccine virus-derived segment 2 into CVV mimics can 96 
improve virus yield for human pdm09 and H3N2 strains, as well as avian H5N1 and 97 
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H7N9 strains [14-22]. Moreover, it has been shown that CVV 5:3 reassortants 98 
containing a pdm09 segment 2 and glycoproteins of avian H5N1 and H7N9 viruses also 99 
give higher yields than their respective 5:3 viruses containing the indigenous pdm09 100 
segment 2, suggesting a particular growth advantage conferred to CVVs by the pdm09 101 
segment 2 [22].  102 
 The fitness advantage conferred by pdm09 segment 2 may be at the genome 103 
packaging level [17, 23, 24], and/or due to a positive contribution from the coding 104 
region of segment 2. Segment packaging signals of the glycoprotein genes are known 105 
to influence yield [14, 25-32] and it has been demonstrated for H3N2 subtype 5:3 106 
reassortants that the NA and PB1 segments co-segregate, driven by interactions in the 107 
coding region of segment 2 [17, 22]. However, this does not exclude contributions from 108 
the encoded proteins, complicated by the fact that segment 2 can produce at least three 109 
polypeptide species: the viral polymerase PB1, a truncated version of PB1, PB1-N40, 110 
and from an overlapping reading frame, a virulence factor PB1-F2 [33-35]. Moreover, 111 
various PR8 strains are used to make HGRs which can give rise to different growth 112 
phenotypes for CVVs containing glycoprotein genes from the same strain/subtype [13, 113 
36]. Overall therefore, a better understanding of the molecular basis for the effects of 114 
vaccine strain-derived segment 2s on growth of reassortant IAVs in eggs is needed, to 115 
better enable rational design of CVVs. 116 
 As a starting point, we rescued CVV mimics that were either 6:2 or 5:3 117 
reassortants between PR8 and pdm09 viruses that differed in whether they contained 118 
pdm09 or PR8 segment 2. The expectation, based on empirical evidence and previous 119 
studies was that the 5:3 reassortants would grow better than the 6:2 ones. This turned 120 
out not to be the case; a result that ultimately led to the identification of PB2 residue 121 
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701D as crucial for facilitating the HGR-enhancing characteristics of pdm09 segment 122 
2 in eggs. 123 
Methods 
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Materials and methods   124 
 125 
Cell lines and viruses 126 
Human embryonic kidney (293T) cells, Madin-Darby canine kidney epithelial 127 
cells (MDCK) and MDCK-SIAT1 (stably transfected with the cDNA of human 2,6-128 
sialtransferase; [37] cells were obtained from the Crick Worldwide Influenza Centre, 129 
The Francis Crick Institute, London. QT-35 (Japanese quail fibrosarcoma; [38]) cells 130 
were obtained from Dr Laurence Tiley, University of Cambridge. Cells were cultured 131 
in DMEM (Sigma) containing 10% (v/v) FBS, 100 U/mL penicillin/streptomycin and 132 
100 U/mL GlutaMAX with 1 mg/ml Geneticin as a selection marker for the SIAT1 133 
cells. IAV infection was carried out in serum-free DMEM containing 100 U/mL 134 
penicillin/streptomycin, 100 U/mL GlutaMAX and 0.14% (w/v) BSA. All viruses used 135 
in this study were made by RG using previously described plasmids for the PR8 [39], 136 
and A(H1N1)pdm2009 strains  A/England/195/2009 (Eng195) [40] and 137 
A/California/07/2009 (Cal7) [41]. CVV strains NYMC X-179A (X-179A) and NYMC 138 
X-181 (X-181) were obtained from the National Institute for Biological Standards and 139 
Control (NIBSC) repository. Virus sequence analyses were performed in part using data 140 
obtained from the NIAID Influenza Research Database (IRD) [42] through the web site 141 
at http://www.fludb.org 142 
 143 
Antisera 144 
Commercially obtained primary antibodies used were: rabbit polyclonal anti-145 
swine H1 HA (Ab91641, AbCam) and mouse monoclonal anti-NP (Ab128193, 146 
AbCam). Laboratory-made rabbit polyclonal anti-NP (2915), anti-M1 (2917) and anti-147 
PB2 have already been described [43-45]. Secondary antibodies used for western blot 148 
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were donkey anti-rabbit DyLight 800 and goat anti-mouse DyLight 680-conjugated 149 
(Licor Biosciences). Secondary antibodies used for staining plaque or TCID50 assays 150 
were goat anti-mouse horseradish peroxidase and goat anti-rabbit horseradish 151 
peroxidase (Biorad).   152 
 153 
Site–directed mutagenesis  154 
 The QuikChange® Lightning site-directed mutagenesis kit (Stratagene) was 155 
used for mutagenesis according to the manufacturer’s instructions. Primers used for 156 
site-directed mutagenesis were designed using the primer design tool from Agilent 157 
technologies.  158 
 159 
Reverse genetics rescue of viruses  160 
 293T cells were transfected with eight pHW2000 plasmids each encoding one 161 
of the IAV segments using Lipofectamine 2000 (Invitrogen). Cells were incubated at 162 
37ºC, 5% CO2 for 6 hours post-transfection before medium was replaced with serum-163 
free virus growth medium. At 2 days post-transfection, 0.5 µg/ml TPCK-treated trypsin 164 
was added to cells. Cell culture supernatants were harvested at 3 days post-transfection, 165 
clarified and used to infect 10-11 day-old embryonated hens’ eggs (Henry Stewart Ltd). 166 
Following incubation for 3 days at 37.5ºC, eggs were chilled overnight and virus stocks 167 
were harvested, titred and partially sequenced to confirm identity.  168 
 169 
RNA extraction, RT-PCR and sequence analysis 170 
Viral RNA extractions were performed using the QIAamp viral RNA mini kit 171 
(QIAGEN) using on-column DNase digestion (QIAGEN). Reverse transcription was 172 
performed with the Uni12 primer (AGCAAAAGCAGG) using the Verso cDNA kit 173 
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(Thermo Scientific). PCR reactions were performed using Pfu Ultra II fusion 145 HS 174 
polymerase (Stratagene) or Taq Polymerase (Invitrogen) according to the 175 
manufacturer’s protocol. PCR products were purified for sequencing by Illustra GFX 176 
PCR DNA and Gel Band Purification kit (GE Healthcare). Primers and purified DNA 177 
were sent to GATC biotech (Lightrun method) for sequencing. Sequences were 178 
analysed using the DNAstar software. 179 
 180 
Virus titration  181 
Plaque assays, TCID50 assays and HA assays were performed according to 182 
standard methods [46]. MDCK or MDCK-SIAT1 cells were used and infectious foci 183 
were visualised by either toluidine blue staining or immunostaining for IAV NP and a 184 
tetra-methyl benzidine (TMB) substrate. HA assays were performed in microtitre plates 185 
using 1% chicken red blood cells in phosphate buffered saline (PBS; TCS Biosciences) 186 
and all titres are given per 50 µl.  187 
 188 
Virus purification and analysis 189 
Allantoic fluid was clarified by centrifugation twice at 6,500 x g for 10 mins. 190 
Virus was then partially purified by ultracentrifugation at 128,000 x g for 1.5 hours at 191 
4ºC through a 30% sucrose in PBS cushion. Pellets were resuspended in PBS and in 192 
some cases treated with N-glycosidase F (PNGase F; New England Biolabs), according 193 
to the manufacturer’s protocol. Virus pellets were lysed in Laemmli’s sample buffer 194 
and separated by SDS-PAGE on 10% or 12% polyacrylamide gels under reducing 195 
conditions. Protein bands were visualised by Coomassie blue staining (Imperial protein 196 
stain, Thermo Scientific) or detected by immunostaining in western blot. Coomassie 197 
stained gels were scanned and bands quantified using ImageJ software. Western blots 198 
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were scanned on a Li-Cor Odyssey Infrared Imaging system v1.2 after staining with the 199 
appropriate antibodies and bands were quantified using ImageStudio Lite software 200 
(Odyssey). 201 
 202 
Quantitative Real-time PCR 203 
RNA extracted from virus pellets (containing partially purified virus from 204 
allantoic fluid pooled from two independent experiments) was reverse transcribed (RT) 205 
using the Uni12 primer with the Verso cDNA kit (Life Technologies), according to the 206 
manufacturer’s instructions. qPCR was based on TaqMan chemistry, primers and 207 
probes were designed using the Primer express software version 3.0.1 (Applied 208 
Biosystems) for Cal7 segments 2 and 6 and PR8 segments 2, 5 and 7. To amplify Cal7 209 
segment 4, Taqman primers/probes were ordered using sequences from the CDC 210 
protocol [47]. Due to nucleotide variations between Cal7 and PR8 segment 2, different 211 
primers/probe were used to amplify the genes from the two strains. Primer and probe 212 
sequences are provided in Table 1. PCR was performed using the Taqman Universal 213 
PCR Master Mix (Applied Biosystems), according to the manufacturer’s instructions 214 
with the recommended cycling conditions. Samples were run on a QuantStudio 12k 215 
Flex machine (Applied Biosystems) and analysed using the QuantStudio 12k Flex 216 
software, applying automatic thresholds. Standard curves were generated using serially 217 
diluted linearised plasmid containing cDNA of the matching genes or RT products from 218 
viruses of known titre. PCR products from both linearised plasmid and cDNA templates 219 
were separated on 3% agarose gels, and fragments of the correct size were 220 
distinguished. DNA was excised from the gels and extracted using the Illustra GFX 221 
PCR DNA and Gel Band Purification Kit (GE Healthcare), according to the 222 
manufacturer’s instructions. PCR products were sequence confirmed by Sanger 223 
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sequencing where sufficient material for sequencing was obtained. qRT–PCR was 224 
performed in triplicate per sample and mock-infected-cell, no-RT (with template) and 225 
no-template controls both from the RT reaction and for the qRT-PCR mix only were 226 
used in each experiment, always giving undetermined cycle threshold (CT) values for 227 
the controls. Relative genome levels were calculated by using CT values for segments 228 
from virus pellets from viruses grown at the different temperatures and interpolating 229 
from standard curves of RT products of RG 5:3 WT virus grown at 37.5C for Cal7 230 
segments 2, 4, 6 and PR8 5 and 7 and for PR8 segment 2 from the standard curve of 231 
RG 6:2 WT virus grown at 37.5C.  232 
 233 
IAV ribonucleoprotein (RNP) reconstitution assays 234 
QT-35 cells at 90% confluency were co-transfected with a chicken RNA 235 
polymerase I:firefly luciferase reporter plasmid flanked with segment 8 untranslated 236 
regions (UTRs), [48] and four pHW2000 plasmids expressing each of the viral protein 237 
components needed to reconstitute RNP complexes using Lipofectamine 2000 238 
(Invitrogen). Triplicate repeats of each assay were performed in parallel at 37.5ºC and 239 
35ºC. At 48 hours post-transfection, the cells were lysed using Reporter Lysis Buffer 240 
(Promega) and luciferase activity measured using Beetle Luciferin (Promega), 241 
reconstituted in H2O and diluted to a final concentration of 0.6mM. Luciferase activity 242 
of each reconstituted RNP was normalised to a ‘No PB2’ negative control. 243 
 244 
Graphs and statistical analyses 245 
Numerical data were plotted using Graphpad Prism software. Tukey’s tests (as 246 
part of one-way ANOVA) were performed using Graphpad Prism version 8.0.2; each P-247 
value was automatically adjusted to account for multiple comparisons.  248 
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Results 249 
 250 
Incorporating a pdm09 segment 2 into CVVs confers temperature sensitivity 251 
 252 
As a starting point, we used RG to rescue candidate vaccine virus (CVV) 253 
mimics that were either 6:2 or 5:3 reassortants between PR8 and the early pdm09 virus 254 
isolates Cal7 and Eng195 that differed in whether they contained a pdm09 or PR8 255 
segment 2 in addition to the pdm09 glycoprotein genes. As comparators, parental (non-256 
reassortant) PR8, Cal7 and Eng195 viruses were also rescued. The expectation, based 257 
on empirical evidence from existing HGRs as well as from published work that used 258 
RG methods [14-22], was that the 5:3 reassortants would grow better than the 6:2 259 
viruses. Viruses were generated by transfecting 293T cells with the desired plasmids, 260 
and amplifying virus in eggs. To assess viral growth, TCID50 titres were determined 261 
on MDCK-SIAT1 cells. As expected, the infectious titre of independently rescued 262 
stocks of the 5:3 reassortants were on average ~ 2-fold higher than the parental pdm09 263 
viruses and ~ 7-fold higher than the 6:2 reassortants, but around 2 log10 lower than WT 264 
PR8 (Figure 1A). The 5:3 viruses also formed larger plaques in MDCK-SIAT cells 265 
than the 6:2 reassortants (data not shown). Surprisingly however, when the HA titres 266 
of virus stocks were measured, the PR8/pdm09 6:2 viruses gave on average ~ 3-fold 267 
higher HA titres than the 5:3 viruses (Figure 1B). When HA:infectivity ratios were 268 
calculated, the RG 6:2 viruses showed on average ~ 30-fold higher values than the RG 269 
5:3 viruses (Figure 1C), suggesting a negative influence of the pdm09 segment 2 on 270 
HA content and/or virus particle infectivity.  271 
To further assess the effect of the pdm09 segment 2 on virus yield, eggs were 272 
inoculated with a dose range from 10 – 1000 TCID50 of virus per egg of the 273 
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PR8:pdm09 reassortant viruses and allantoic fluid titre measured by HA assay 274 
following incubation at 37.5°C for 3 days. The yield of each virus was insensitive to 275 
input dose, with no significant differences between average titres within each group of 276 
viruses (Figures 2A, B). However, at all doses, the RG Cal7 and Eng195 6:2 277 
reassortants gave higher average HA titres than their 5:3 counterparts, and these 278 
differences were mostly statistically significant. As before (Figure 1), this was the 279 
opposite of the anticipated result, based on the known compositions of conventionally 280 
selected pdm09-based CVVs [11]. However, influenza vaccine manufacture often 281 
involves incubation of the eggs at temperatures below 37.5°C [49], so we therefore 282 
tested the outcome of growing the reassortant viruses in eggs incubated at 35°C. Again, 283 
average HA titres were insensitive to inoculum dose, but the differences between the 284 
5:3 and 6:2 pairs were much reduced and no longer statistically significant. (Figures 285 
2C, D).  Growth of both the 6:2 and 5:3 PR8:Cal7 reassortants was improved at 35°C 286 
compared to 37.5°C, by around 2-4 fold for the 6:2 virus but by 8-16 fold for the 5:3 287 
virus (Figures 2A, C). Yield of the 6:2 PR8:Eng195 virus was not increased by growth 288 
at the lower temperature but substantial gains of around 4-fold were seen with the 5:3 289 
reassortant (Figures 2B, D). Thus the 5:3 viruses including a pdm09 segment 2 290 
appeared to be more temperature sensitive than the RG 6:2 viruses.  291 
 292 
RG 5:3 and 6:2 reassortants differ in their incorporation of HA into virus particles 293 
at different temperatures 294 
 295 
To directly assess HA protein yield, virus particles from each experiment were 296 
partially purified from equal volumes of pooled allantoic fluid by pelleting through 30% 297 
sucrose cushions. HA1 content from virus pellets was analysed by SDS-PAGE and 298 
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western blotting either before or after treatment with PNGaseF to remove glycosylation. 299 
This gave the expected alternating pattern of slow and faster-migrating HA polypeptide 300 
species (Figures 3A,B top row). The amount of HA1 fluctuated between samples but 301 
for both Cal7 and Eng195 reassortants, yield was generally higher from viruses grown 302 
at 35°C than 37.5°C and highest from the 6:2 reassortants. To test the reproducibility 303 
of this, de-glycosylated HA1 was quantified from the western blots of replicate 304 
experiments. Absolute HA1 yield was variable, but across a total of 5 independent 305 
experiments with 4 technical replicates, the average HA1 recovery from both PR8:Cal7 306 
and PR8:Eng195 5:3 and 6:2 viruses was improved by growth at 35°C, but by a greater 307 
factor (nearly 5-fold versus 3-fold) for the 5:3 reassortants (Figure 3C).      308 
 To test to what extent the varying HA1 yields reflected difference in virus 309 
growth and/or HA content of the virus particles, we investigated virion composition by 310 
determining the relative amounts of HA1 to the other two major structural polypeptides, 311 
NP and M1. Western blotting showed reasonably consistent amounts of the latter two 312 
proteins in the PR8:Cal7 preparations (Figure 3A), but more variable and generally 313 
lower recovery of NP in the PR8:Eng195 viruses, especially for the 6:2 virus at 37.5°C 314 
(Figure 3B). Quantification of these proteins from four independent experiments with 315 
the PR8:Cal7 viruses (where the higher growth of the viruses allowed more reliable 316 
measurements) showed that the NP:M1 ratios were reasonably consistent and not 317 
obviously affected by the incubation temperature of the eggs or the source of segment 318 
2 (Figure 3D). However, the RG 5:3 virus showed a significantly higher NP:HA1 ratio 319 
than the 6:2 virus when grown at 37.5°C but not at 35°C (Figure 3E). Therefore, the 320 
inclusion of the pdm09-derived segment 2 into the PR8 reassortants led to lower HA 321 
content in virus particles, especially when grown at the higher temperature. 322 
 323 
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The Cal7 segment 2 does not confer temperature sensitivity to HGRs X-179A 324 
and X-181 325 
 326 
Following the observation of temperature sensitivity of our RG 5:3 viruses, we 327 
tested whether growth of the RG WT pdm09 viruses and corresponding conventional 328 
HGR viruses were similarly affected by temperature. Viruses were grown in eggs at 329 
35°C or 37.5°C and the resulting HA titres plotted as fold increases in growth at the 330 
lower temperature. Titres of RG viruses containing a PR8 segment 2 were only 331 
modestly (~ 2-4 fold) affected by temperature, but those of viruses containing a pdm09 332 
segment 2 were ~ 8-16-fold higher at 35°C than 37.5°C (Figure 4; compare solid blue 333 
and red bars). However, the yield of the conventionally reassorted authentic 5:3 HGRs 334 
X-179A and X-181 (both containing a segment 2 from Cal7 and five other internal gene 335 
segments from PR8) were only ~3-4 fold higher at the lower temperature. Thus, the 336 
Cal7 segment 2 gene behaved differently in conventional and RG reassortant virus 337 
settings; presumably because of sequence polymorphisms in either segment 2 itself 338 
and/or the PR8 backbone between what should be, at first sight, equivalent viruses.  339 
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Internal segments of RG PR8 and HGR X-179A differ  340 
 341 
To understand the molecular basis of the temperature sensitivity conferred by 342 
RG derived pdm09 segment 2 compared to authentic HGRs, amino-acid sequence 343 
comparisons were made between the pdm09-derived genes of the RG viruses used in 344 
this study versus those of the HGRs X-179A and X-181. The NA sequences of all four 345 
viruses, RG Cal7, RG Eng195, X-179A and X181, were identical (Table 2A). The HA 346 
polypeptides of the Cal7, X-179A and X-181 viruses were very similar, differing only 347 
with a T209K in the Cal7 sequence and a N129D substitution in the X-181 sequence, 348 
while the Eng195 HA varied at four positions from all three other viruses and also 349 
differed from the HGR viruses in T209K. Within segment 2, the apparent source of the 350 
temperature sensitivity, only RG Eng195 differed from the other isolates, with a single 351 
amino acid change (R353K). There were no changes in the truncated 11 codon PB1-F2 352 
gene for any of the viruses. Therefore, given the lack of any consistent differences 353 
between the two RG pdm09 clones and the conventional HGR viruses, the generally 354 
poor and highly temperature sensitive HA yield of the RG 5:3 viruses seemed unlikely 355 
to be due to segment 2. Instead, we hypothesised that it was due to epistatic effects 356 
arising from sequence differences in the PR8 internal segments of the viruses. 357 
Comparison of the internal gene sequences of our RG PR8 (Erasmus [39]) and X-179A 358 
(internal gene sequences were not available for X-181 at this time) showed no coding 359 
differences in segments 3 and 7, but several in segment 8 (five in NS1 and one in NS2) 360 
and one each in PB2 and NP (Table 2B). Amongst these changes, the PB2 N701D 361 
polymorphism has been previously linked with host-adaptive changes including 362 
temperature sensitivity by several studies [50-58]. Furthermore, PB2 N701D is 363 
phenotypically linked with the dominant PB2 host-adaptive polymorphism E627K 364 
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which also affects temperature sensitive viral polymerase activity [59-61]. This 365 
therefore suggested the hypothesis that the PR8 PB2 contributed to the temperature 366 
sensitive phenotype seen here. 367 
To test if the temperature sensitivity conferred by segment 2 of pdm09 viruses could 368 
be attributed to effects on viral polymerase activity, we performed RNP reconstitution 369 
assays using the readily-transfectable avian QT-35 Japanese quail fibrosarcoma cell line at 370 
both 37.5ºC and 35ºC. Cells were transfected with plasmids to reconstitute RNPs encoding 371 
a luciferase reporter gene [59] using either all four PR8 RNP polypeptides, or, to 372 
recapitulate RNPs of the 5:3 reassortant virus, PB1 from Cal7 and PB2, PA and NP from 373 
PR8. In the latter “5:3” background, the PB2 and NP polymorphisms were tested, singly 374 
and in combination, while a negative control lacked a source of PB2. In all cases, increased 375 
transcriptional activity of the reconstituted RNPs was observed at the cooler temperature 376 
of 35ºC, while RNPs containing the Cal7 PB1 protein displayed greater transcriptional 377 
activity at both 35ºC and 37.5ºC than those containing PR8 PB1 (Figure 5A). However, 378 
when the ratios of activities at 35°C:37.5°C were calculated, the Cal7 PB1 did not confer 379 
greater temperature-dependency on the RNP than PR8 PB1 (Figure 5A, green data points). 380 
Introducing the PB2 N701D and NP T130A mutations into RNPs incubated at 37.5°C had 381 
relatively little effect on viral gene expression, even when both changes were made to 382 
reconstitute X179A RNPs. Surprisingly, the PB2 mutation significantly affected RNP 383 
activity at 35°C, but by lowering it. Consequently, the ratios of activities at 35°C:37.5°C 384 
showed a clear effect of the PB2 (but not the NP) mutation on the temperature-dependency 385 
of the RNP. Examination of cell lysates by SDS-PAGE and western blotting for viral 386 
proteins PB2 and NP did not show any major differences in their accumulation (Figure 387 
5B). Thus, in the context of a ‘minireplicon’ assay, the Cal7 PB1 did not render RNPs more 388 
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temperature sensitive, but the PR8 PB2 N701D polymorphism significantly affected the 389 
temperature-dependency of the 5:3 virus RNP. 390 
 391 
PB2 N701D reduces temperature sensitivity of the RG 5:3 virus  392 
 393 
To test the significance of the sequence polymorphisms between X-179A and our 394 
PR8 internal genes, we attempted rescues of a panel of PR8:Cal7 5:3 viruses using either 395 
the WT RG PR8 backbone, PB2 N701D, NP T130A, the NS mutant (NS1 K55E, M104I, 396 
G113A, D120G and A132T, and NS2 E26G) or a ‘triple mutant’ containing the mutated 397 
PB2, NP and NS genes that would, in protein-coding terms, recreate an RG X-179A. 398 
Unexpectedly, viruses with the mutated segment 8 (either singly or as the triple mutant) did 399 
not rescue on multiple attempts (data not shown). The reasons for this are not clear, but are 400 
suggestive of a detrimental effect on virus replication. However, the PB2 and NP mutants 401 
rescued readily and their growth in eggs was further characterised. When HA yield of these 402 
viruses at 37.5ºC and 35ºC was assessed by HA assay, as before the 5:3 WT virus was 403 
temperature sensitive, giving significantly lower titres at 37.5°C (Figure 6A). The 5:3 NP 404 
mutant behaved similarly to the 5:3 WT virus at both temperatures, also showing strong 405 
temperature sensitivity. In contrast, the PB2 N701D mutant showed a lesser (but still 406 
statistically significant) drop in titre at 37.5°C and furthermore, gave significantly higher 407 
HA titres than WT 5:3 at both temperatures. To further test whether the PB2 N701D 408 
mutation increased HA yield of the 5:3 CVV mimic, 5:3 WT and PB2 mutant viruses were 409 
partially purified from allantoic fluid and examined by western blot for HA, with or without 410 
prior de-glycosylation, as well as NP and M1. Consistent with the HA titre data, both 411 
viruses gave greater amounts of these major structural polypeptides following growth at 412 
35°C than 37.5°C, but with the 5:3 PB2 mutant out-performing the 5:3 WT virus (Figure 413 
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6B). Levels of de-glycosylated HA1 were quantified by densitometry of western blots 414 
across replicate experiments, showing that the 5:3 WT virus gave on average a 3.6-fold 415 
increase in HA1 yield at 35°C compared with 37.5°C, whereas the 5:3 PB2 N701D virus 416 
showed only a 1.6-fold increase (Figure 6C), confirming that the PB2 N701D 417 
polymorphism reduced the temperature sensitivity of HA yield in eggs. No significant 418 
differences in NP:HA1 and NP:M1 ratios were seen between viruses (data not shown). 419 
Finally, we investigated the effects of temperature and the PB2 mutation on the infectivity 420 
of the 5:3 viruses. To define relative infectivity values, we derived genome copy to 421 
infectivity ratios for the WT 5:3 reassortant, the PB2 mutant and the authentic X-179A 422 
HGR viruses grown at high and low temperatures. RNA from virus pellets was extracted, 423 
reverse transcribed and quantitative real-time PCR performed to determine the relative 424 
amounts of genome in virions. All viruses incorporated similar levels of segments 2, 4, 5, 425 
6 and 7 and there was no indication of selective defective packaging of a particular segment 426 
from any of the viruses grown at the different temperatures (data not shown). Virus 427 
infectivity was then determined for each virus sample by TCID50 assay and used to calculate 428 
genome copy:infectivity ratios, normalised to X179-A virus grown at 35°C. All viruses, 429 
including X-179A, showed worse particle:infectivity ratios when grown at 37.5°C (Figure 430 
6D). HA:infectivity ratios showed a similar trend (data not shown). However, the WT 5:3 431 
RG reassortant virus had an approximately 250-fold higher genome:infectivity ratio than 432 
X-179A when grown at 35°C and this was partially (but not completely) restored by the 433 
PB2 N701D change. Therefore, having PB2 701D is beneficial to the growth and HA yield 434 
of a 5:3 CVV with pdm09 HA, NA and PB1. 435 
 436 
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Discussion 437 
Several studies in recent years have shown positive effects of incorporating pdm09 438 
segment 2 into RG CVV mimics on yield for human pdm09 and H3N2 strains and avian 439 
H5N1 and H7N9 strains [14-22]. In our study, we surprisingly found that for two pdm09 440 
strains, an RG 6:2 virus containing the PR8 segment 2 gave higher HA yield in eggs than 441 
the counterpart viruses containing the pdm09 segment 2. Moreover, the RG 5:3 virus had 442 
a markedly greater temperature sensitive phenotype compared with the RG 6:2 viruses, as 443 
well as with very similar 5:3 genotype classical HGRs. Comparison of amino acid 444 
sequence differences between our RG 5:3 viruses and authentic 5:3 HGRs suggested the 445 
hypothesis that this was down to epistatic interactions between the pdm09 segment 2 and 446 
the internal PR8 genes. Further mutational analysis of the PR8 backbone employed here 447 
indicated that the PB2 D701N polymorphism was a major contributor to this genetic 448 
incompatibility. 449 
Altering the backbone of our PR8 strain to contain PB2 701D did not completely 450 
convert the phenotype of our RG 5:3 CVV mimic to that of its closest authentic HGR 451 
counterpart, X-179A in terms of growth in eggs (Figure 6C). It may be that one or more 452 
of the other amino acid polymorphisms between the PR8 genes in segments 5 and 8 also 453 
contribute. The single difference in NP, T130A, did not affect minireplicon activity 454 
(Figure 5) or HA yield in eggs (Figure 6 and data not shown). It lies in the RNA and PB2 455 
binding regions of the protein but the functional significance of differences at this residue 456 
are unclear. We were unable to test the significance of the segment 8 polymorphisms as 457 
the version of the segment mutated to match that in X-179A could not be rescued into a 458 
viable virus, either singly, or when combined with the mutated segment 2 and 5 to 459 
supposedly recreate X-179A. The reasons for this are not clear. Possibly by focussing on 460 
coding changes only, we missed an essential contribution from a non-coding change (of 461 
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which there are several between our 5:3 Cal7 reassortant and X-179A, not just in segment 462 
8). Murakami et al., 2008 showed that K55E (in the RNA binding domain) of NS1 463 
mediates growth enhancement of CVVs in MDCK cells [62]. The other amino acid 464 
differences are in the effector domain of NS1: position 104 is adjacent to residues known 465 
to affect interactions with the cellular cleavage and polyadenylation specificity factor 466 
(CPSF), position 113 is in the eukaryotic initiation factor 4GI (eIF4GI)-binding domain, 467 
position 120 is in the 123-127 PKR-binding and potential polymerase-binding region and 468 
position 132 is close to a nuclear export signal (reviewed in [63]). However, any effects 469 
of these precise amino acid differences in NS1 and NS2 are not well documented.  470 
Subsequent sequencing of X-181 (sequences available via the Global Initiative on 471 
Sharing All Influenza Data database under accession numbers EPI1393941-8) showed that 472 
it also contains PB2 N701D, one difference in NP, I116M (which also lies in the RNA and 473 
PB2 binding regions of the protein), and only one difference in NS1, K55E, when 474 
compared with our PR8 strain. Thus although we did not test the significance of the NP 475 
and NS1 polymorphisms, it is plausible that like X179-A, PB2 701D explains the low 476 
temperature sensitivity of this HGR. 477 
The exact mechanism of how PB2 N701D reduces temperature sensitivity of our 478 
RG-derived 5:3 virus remains to be elucidated, although our results suggest it may be at the 479 
level of viral polymerase activity. Introducing this change into the PR8/Cal7 PB1 480 
polymerase reduced the apparent temperature sensitivity of the viral RNP but by decreasing 481 
activity at the lower temperature of 35 °C rather than by increasing activity at the higher 482 
temperature (Figure 5). This does not permit a simple correlation to be drawn between the 483 
effect of the mutation in the artificial sub-viral minireplicon assay and the behaviour of the 484 
complete virus in eggs, but is nonetheless suggestive of a functionally important link. The 485 
opposite change, PB2 D701N, has been shown to enhance the interaction of PB2 with 486 
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mammalian importin 1 [52], so it would be interesting to examine this from the 487 
perspective of adaptation to an avian host. Interactions between PB2 and importin  have 488 
also been suggested to play a role in viral genome replication [64]; the minireplicon assay 489 
used here primarily interrogates transcription, so this could also be an avenue to explore 490 
further. 491 
 Of the over a hundred PB2 sequences from conventionally reassorted viruses 492 
(mostly X-series viruses) available on the Influenza Research Database (accessed 493 
December 2018), the vast majority (117/118) have PB2 701D, with a single virus 494 
having a glutamate residue. Of the 35 PR8 PB2 sequences available, 701N is a minority 495 
variant, only appearing in two viruses; the one used here, and in a “high growth” PR8 496 
derived by serial passage in MDCK cells with the aim of producing a high-yielding 497 
backbone constellation for  RG vaccine reassortant production in mammalian cells  498 
[65]. In this study, the parental PR8 virus possessed PB2 701D before passaging and 499 
analysis of reassortant characteristics suggested that this adaptive change was important 500 
for growth in cells. Moreover, it has been shown that viruses with PB2 701N were 501 
detected in eggs incubated at 33ºC but not at 37ºC after inoculation with a clinical 502 
specimen, suggesting that a lower temperature may be favoured by PB2 701N viruses 503 
[66], similar to our study which shows that PB2 701N has a temperature sensitive 504 
phenotype. The PR8 clone we used is a descendant of the NIBSC PR8 strain used to 505 
make vaccine reassortants, produced by serial passage in MDCK cells [39]; adaptive 506 
changes were not determined, but comparison with the NIBSC PR8 PB2 sequence (data 507 
not shown) suggests that it did indeed acquire the PB2 D701N change. The data 508 
reported here are the reciprocal of those reported by Suzuki and colleagues [65] and 509 
further underscore the importance of PB2 701 as a key residue  for design of  an optimal 510 
RG backbone depending on whether the vaccine is to be grown in eggs or mammalian 511 
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cells. With such information, yield of RG vaccines may be improved, which would be 512 
beneficial during pandemics where manufacturers have struggled to meet demand, such 513 
as during the 2009 A(H1N1) pandemic [67].  514 
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TABLE 1. Taqman primers and probes for amplification of Influenza genomic segments by real time RT-
PCR 
 
Segment Strain Forward primer 5'-3' Reverse primer 5'-3' Probe 5' FAM- 3' TAMRA 
Nucleotide 
position of 
amplicon 
2 Cal7 GCTCCAATCATCCGACGATT CTGCTTGTATTCCCTCATGGTTT CTCTCATAGTGAATGCAC 1344-1408 
4 Cal7 GTGCTATAAACACCAGCCTCCCA CGGGATATTCCTCAATCCTGTGGC CAGAATATACATCCGATCACAATTGGAAAA 934-1049 
6 Cal7 AATCACATGTGTGTGCAGGGATA GAAAGACACCCACGGTCGAT CTGGCATGGCTCG 881-938 
2 PR8 GAGATACACCAAGACTACTTA GGTGCATTCACAATCAGAG CTGGTGGGATGGTCTTCAATCCTC 1311-1385 
5 PR8 AGCATTCAATGGGAATACAGA CCCTGGAAAGACACATCTT TCTGACATGAGGACCGAAATCATAAGGA 1326-1424 
7 PR8 CCTGGTATGTGCAACCTGTGAA TGGATTGGTTGTTGTCACCATT AGATTGCTGACTCCCAGCATCGG 460-538 
Primer/probe sequences for Cal7 segment 4 obtained from the CDC [47]. 
 
 
 
 
FIGURE 1. Effect of segment 2 source on virus growth. Virus stocks were grown 
in eggs and titred by A) TCID50 assay on MDCK-SIAT cells or B) by HA assay. C) 
shows the ratio of HA: infectivity titres, arbitrarily scaled by a factor of 106. Data 
points are from independently rescued stocks. Filled circles represent viruses 
with Cal7 glycoproteins and open circles Eng195. Bars represent the mean and 
SEM. Differences between the viruses containing pdm09 segments were not 
statistically significant. 
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FIGURE 2. HA yield of PR8:pdm09 5:3 and 6:2 CVV mimics grown at 37.5°C or 
35°C. HA titres from allantoic fluid of embryonated eggs infected with 
reassortants derived from A, C) Cal7 or B, D) Eng195 grown at 37.5°C (A, B) or 
35°C (C, D) at 3 days p.i.. Bars indicate mean and SEM of 3 independent 
experiments (5 eggs per condition in an experiment) for PR8:Cal7 reassortants 
(from two independently rescued RG stocks), and a single experiment for 
PR8:Eng195 reassortants. Horizontal bars indicate statistical significance (*p  
0.05, **p < 0.01), assessed by Tukey’s test. 
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FIGURE 3. Relative virion composition of viruses grown at 37.5°C versus 
35°C. Western blots of purified virus preparations from allantoic fluid of 
embryonated eggs infected with A) PR8:Cal7 or B) PR8:Eng195 reassortants 
grown at 37.5°C or 35°C at 3 days p.i.. Equal volumes of virus samples were either 
treated with PNGase F (+) or left untreated (-), separated by SDS-PAGE on a 4-20% 
polyacrylamide gel and virus proteins HA1, NP and M1 detected by western 
blotting and quantified by densitometry. C, D, E) HA1 yield (de-glycosylated), and 
ratios of NP:M1 and M1:HA1 (de-glycosylated) respectively. Bars indicate mean 
and SEM from 5 independent virus yield experiments (4 experiments with 
PR8:Cal7 reassortants (filled symbols) using 2 independent RG stocks and a single 
experiment with PR8:Eng195 reassortants (open symbols)). Horizontal bars 
indicate statistical significance assessed by Tukey’s test (*p  0.05). 
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FIGURE 4. Relative HA titre of RG WT, RG reassortant and HGR viruses 
containing pdm09 or PR8 segment 2 at 35 °C versus 37.5 °C. For each 
independent experiment, the fold increase in HA titre of viruses grown at 35°C 
versus 37.5°C at 3 days p.i. was calculated. Bars indicate mean and SEM from 2-10 
independent experiments for each virus. Horizontal bars indicate statistical 
significance (*p  0.05, **p < 0.01), assessed by Tukey’s test. 
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Table 2. Amino acid sequence differences between RG CVV mimic and HGR 
viruses 
 
A) 
Protein Cal7 Eng195 X-179A X-181 
PB1  K353R   
HA T209K L32I, 
P83S,  
T209K, 
R223Q, 
I321V 
 N129D 
NA     
 
B) 
Protein No. differences  
PR8 vs X-179A 
Amino acid changes 
(PR8 > X-179A) 
PB2 1 N701D 
PA 0  
NP 1 T130A 
M1 (M2) 0  
NS1 
(NS2) 
5 (1) K55E, M104I, G113A, 
D120G, A132T (E26G) 
 
A). Variations from the consensus sequences of the pdm09 PB1, HA and NA 
polypeptides of the indicated viruses. Sequence accession numbers (segments 
2,4 and 6 respectively): Cal7 EPI1355048, EPI1355049, EPI1355051; Eng195 
GQ166655.1, GQ166661.1, GQ166659.1; X-179-A CY058517.1, CY058519, 
CY058521; X-181 GQ906800, GQ906801, GQ906802. 
B). Sequence differences between the backbone-encoded polypeptides of RG PR8 
and X-179A. Sequence accession numbers (segments 1,3, 5, 7, 8 respectively): 
PR8 EF467818, EF467820, EF467822, EF467824, EF467817; X179A CY058516, 
CY058518, CY058520, CY058522, CY058523. 
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FIGURE 5. Effect of temperature on RNP activity in avian cells. QT-35 cells 
were co-transfected with plasmids expressing a synthetic vRNA encoding 
luciferase along with either Cal7 (red bars) or PR8 PB1 (blue bars) as well as PA, 
PB2 and NP from PR8, with PB2 and NP either being WT or PB2 N701D (PB2m) 
and/or NP T130A (NPm) as indicated (RNPs reconstituted with the Cal7 PB1 and 
both PB2 and NP mutants are equivalent to and labelled as X-179A). Replicate 
transfections were incubated at 37.5°C or 35°C and at 48 h post-transfection, cells 
were lysed and luciferase activity measured. A) Luciferase activity at each 
temperature was calculated as fold increases over a negative control lacking PB2 
(-PB2), and then normalised to the activity seen from RNPs with Cal7 PB1 and WT 
PR8 PB2, PA and NP components (WT) at 37.5°C. Data are plotted as bar graphs 
using the left hand y axis. Statistical significance is indicated (**p < 0.01, ***p < 
0.001), assessed by Tukey’s test. To assess the temperature sensitivity of the 
various RNPs, the ratio of activity at 35°C:37.5°C was calculated and plotted as 
column means (green diamonds) using the right hand y axis. All values are mean 
and SEM of 4 independent experiments, with transfections performed in triplicate. 
B) Cell lysates from parallel transfections were analysed by SDS-PAGE and 
western blotting for viral proteins PB2 and NP. Tubulin (tub) was employed as a 
loading control.  
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FIGURE 6. Yield assessment of PR8:Cal7 5:3 mutants grown in eggs at 35°C and 37.5°C. 3 
A) HA titres from allantoic fluid of embryonated eggs infected with PR8:Cal7 6:2 and 5:3 4 
mutants grown in eggs at 35°C and 37.5°C at 3 days p.i.. Bars indicate mean and SEM from 5 
4 independent experiments using 2 independently rescued stocks of virus for WT and PB2m 6 
and 3 independent experiments with a single rescue for NPm (4 - 7 eggs per condition in an 7 
experiment). Statistical significance is indicated (*p  0.05, **p < 0.01, ***p < 0.001), 8 
assessed by Tukey’s test. B) Representative western blot of partially purified virus from 9 
pooled allantoic fluid. Equal volumes of each virus sample were either treated with PNGase 10 
F (+) or left untreated (-), separated by SDS-PAGE on a 4-20% polyacrylamide gel and 11 
analysed by western blotting to detect HA1, NP and M1. Molecular mass markers (kDa) are 12 
also shown. C) De-glycosylated HA1 was quantified by densitometry from three 13 
independent experiments, two with technical replicates. D) RNA was extracted from virus 14 
pellets and qRT-PCR performed to quantify amounts of the indicated segments. Data are 15 
plotted as the ratio of genome copy number to infectivity (separately determined by TCID50 16 
assay) relative to the value obtained for X-179A grown at 35°C. Error bars reflect the mean 17 
and standard deviation of qPCR performed in triplicate per sample. 18 
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